Loading...

RSLS RESHAPE LIFESCIENCES INC Capital Structure Changes 8-K Filing

RSHP

RSLS

RESHAPE LIFESCIENCES INC

(RSLS)

2025 8-K

Show Summary

Show Summary

Compliance Status

Equity Offerings

Equity Offerings

Equity Offerings

Forced Delisting

Merger of Equals

Asset Acquisitions

Stockholder Approvals

Director Resignation

Securities Offering

Convertible Note Issued

Equity Purchase Agreement

Earnings Report

Nasdaq Compliance Issue

Financial Results

Securities Agreement

Financial Results

Merger Agreement and Asset ...

Financial Results Announcement

Changes in Registrant's Cer...

Financial Results Announcement

Warrant Exercise Agreement

Financial Results Announcement

Securities Purchase Agreement

Exclusive License Agreement...

Earnings Reports

Financial Results Announcement

Securities Purchase Agreement

Financial Restatement

Lease Agreement

Public Offering

Amendment to Registration S...

External Links:

On February 15, 2025, ReShape Lifesciences Inc. entered into a Securities Purchase Agreement to sell 2,575,107 shares and warrants for approximately $6.0 million, closing on February 18, 2025, to fund its merger with Vyome Therapeutics and other corp

AI Assistant

RESHAPE LIFESCIENCES INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.